These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 12662138

  • 1. T cell costimulatory pathways: blockade for autoimmunity.
    Najafian N, Khoury SJ.
    Expert Opin Biol Ther; 2003 Apr; 3(2):227-36. PubMed ID: 12662138
    [Abstract] [Full Text] [Related]

  • 2. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T, Ueno T, Clarkson MR, Yuan X, Jurewicz MM, Yagita H, Azuma M, Sharpe AH, Auchincloss H, Sayegh MH, Najafian N.
    J Immunol; 2005 Jun 01; 174(11):6648-56. PubMed ID: 15905503
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of CTLA-4-Ig in tolerance induction.
    Alegre ML, Fallarino F.
    Curr Pharm Des; 2006 Jun 01; 12(2):149-60. PubMed ID: 16454732
    [Abstract] [Full Text] [Related]

  • 4. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.
    Dilek N, Poirier N, Hulin P, Coulon F, Mary C, Ville S, Vie H, Clémenceau B, Blancho G, Vanhove B.
    PLoS One; 2013 Jun 01; 8(12):e83139. PubMed ID: 24376655
    [Abstract] [Full Text] [Related]

  • 5. Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.
    Fife BT, Bluestone JA.
    Immunol Rev; 2008 Aug 01; 224():166-82. PubMed ID: 18759926
    [Abstract] [Full Text] [Related]

  • 6. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.
    Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC, Horton HF, Fouser L, Carter L, Ling V, Bowman MR, Carreno BM, Collins M, Wood CR, Honjo T.
    J Exp Med; 2000 Oct 02; 192(7):1027-34. PubMed ID: 11015443
    [Abstract] [Full Text] [Related]

  • 7. The B7-CD28 superfamily.
    Sharpe AH, Freeman GJ.
    Nat Rev Immunol; 2002 Feb 02; 2(2):116-26. PubMed ID: 11910893
    [Abstract] [Full Text] [Related]

  • 8. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.
    Carreno BM, Collins M.
    Annu Rev Immunol; 2002 Feb 02; 20():29-53. PubMed ID: 11861596
    [Abstract] [Full Text] [Related]

  • 9. The B7 family revisited.
    Greenwald RJ, Freeman GJ, Sharpe AH.
    Annu Rev Immunol; 2005 Feb 02; 23():515-48. PubMed ID: 15771580
    [Abstract] [Full Text] [Related]

  • 10. The CD28-B7 costimulatory pathway and its role in autoimmune disease.
    Daikh D, Wofsy D, Imboden JB.
    J Leukoc Biol; 1997 Aug 02; 62(2):156-62. PubMed ID: 9261329
    [Abstract] [Full Text] [Related]

  • 11. Absence of B7-dependent responses in CD28-deficient mice.
    Green JM, Noel PJ, Sperling AI, Walunas TL, Gray GS, Bluestone JA, Thompson CB.
    Immunity; 1994 Sep 02; 1(6):501-8. PubMed ID: 7534617
    [Abstract] [Full Text] [Related]

  • 12. CD28 function: a balance of costimulatory and regulatory signals.
    Bour-Jordan H, Blueston JA.
    J Clin Immunol; 2002 Jan 02; 22(1):1-7. PubMed ID: 11958588
    [Abstract] [Full Text] [Related]

  • 13. T cell costimulatory and inhibitory receptors as therapeutic targets for inducing anti-tumor immunity.
    Foell J, Hewes B, Mittler RS.
    Curr Cancer Drug Targets; 2007 Feb 02; 7(1):55-70. PubMed ID: 17305478
    [Abstract] [Full Text] [Related]

  • 14. [Costimulatory molecules in autoimmunity: role of CD28/CTLA4-CD80/CD86].
    Nakajima A, Azuma M.
    Nihon Rinsho; 1997 Jun 02; 55(6):1419-24. PubMed ID: 9200926
    [Abstract] [Full Text] [Related]

  • 15. Inhibitors of B7-CD28 costimulation in urologic malignancies.
    Thompson RH, Kwon ED, Allison JP.
    Immunotherapy; 2009 Jan 02; 1(1):129-39. PubMed ID: 20445772
    [Abstract] [Full Text] [Related]

  • 16. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.
    Lee RS, Yamada K, Womer KL, Pillsbury EP, Allison KS, Marolewski AE, Geng D, Thall AD, Arn JS, Sachs DH, Sayegh MH, Madsen JC.
    J Immunol; 2000 Mar 15; 164(6):3434-44. PubMed ID: 10706740
    [Abstract] [Full Text] [Related]

  • 17. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation.
    Salomon B, Bluestone JA.
    Annu Rev Immunol; 2001 Mar 15; 19():225-52. PubMed ID: 11244036
    [Abstract] [Full Text] [Related]

  • 18. CD28-independent costimulation of T cells in alloimmune responses.
    Yamada A, Kishimoto K, Dong VM, Sho M, Salama AD, Anosova NG, Benichou G, Mandelbrot DA, Sharpe AH, Turka LA, Auchincloss H, Sayegh MH.
    J Immunol; 2001 Jul 01; 167(1):140-6. PubMed ID: 11418642
    [Abstract] [Full Text] [Related]

  • 19. T cell costimulatory blockade: new therapies for transplant rejection.
    Gudmundsdottir H, Turka LA.
    J Am Soc Nephrol; 1999 Jun 01; 10(6):1356-65. PubMed ID: 10361876
    [Abstract] [Full Text] [Related]

  • 20. Potential roles of the B7 and CD28 receptor families in autoimmunity and immune evasion.
    Harlan DM, Abe R, Lee KP, June CH.
    Clin Immunol Immunopathol; 1995 May 01; 75(2):99-111. PubMed ID: 7535672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.